A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease-Reference-Cited by-同舟云学术

A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease

Published:2023-10 Issue:10 Volume:5 Page:100845
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Hammoutene Adel^ORCID,Laouirem Samira,Albuquerque Miguel^ORCID,Colnot Nathalie,Brzustowski Angélique,Valla Dominique^ORCID,Provost Nicolas,Delerive Philippe^ORCID,Paradis Valérie

Funder

Servier

Institut National de la Santé et de la Recherche Médicale

Université de Paris

Centre National de la Recherche Scientifique

Agence Nationale de la Recherche

Commissariat à l'Énergie Atomique et aux Énergies Alternatives

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference70 articles.

1. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality;Karlsen;Lancet Lond Engl,2022

2. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2018

3. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease;Estes;Hepatology,2018

4. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease;Eslam;Gastroenterology,2020

5. Mechanisms of NAFLD development and therapeutic strategies;Friedman;Nat Med,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carthamus tinctorius L. (Safflower) Flower Extract Attenuates Hepatic Injury and Steatosis in a Rat Model of Type 2 Diabetes Mellitus via Nrf2-Dependent Hypoglycemic, Antioxidant, and Hypolipidemic Effects;Antioxidants;2024-09-10

2. Revisiting liver metabolism through acetyl-CoA carboxylase inhibition;Trends in Endocrinology & Metabolism;2024-07

3. Estrogen-dependent TRX2 activation reverts oxidative stress and metabolic dysfunction associated to steatotic disease;2024-04-27

4. MAFLD as part of systemic metabolic dysregulation;Hepatology International;2024-04-09

5. Inflammatory liver diseases and susceptibility to sepsis;Clinical Science;2024-04